Public Awareness and Understanding of PC in the UAE
Public Awareness and Understanding of Palliative Care in the United Arab Emirates: Insights from a Population-Based Cross-Sectional Study
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Abu Dhabi, United Arab Emirates
- Burjeel Cancer Institute
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- UAE residents
- Provided informed consent to participate
- Completed the survey in either Arabic or English
Exclusion Criteria:
- Non-UAE residents
- Incomplete survey responses (if applicable)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Familiarity and Understanding of Palliative and Supportive Care as Measured by a Structured Survey
Time Frame: Surveys were conducted in Arabic from July 25, 2024, to August 18, 2024, and in English from August 5, 2024, to August 18, 2024.
|
The study assessed participants' awareness, familiarity, and understanding of palliative and supportive care through a structured questionnaire. The survey includes Likert-scale and multiple-choice questions designed to evaluate:
Responses were analyzed quantitatively by calculating the proportion of participants at different familiarity levels i.e., Very familiar, somewhat familiar, Neutral/not sure, not very familiar, not familiar at all and comparing trends across language groups. Percentages were calculated and categorical responses were summarized using frequency distributions. |
Surveys were conducted in Arabic from July 25, 2024, to August 18, 2024, and in English from August 5, 2024, to August 18, 2024.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- BH/REC/073/24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.